Table 3.
Therapies under development for CLE
| Medication | Phase of clinical trial completed |
| BIIB059 | Phase II |
| Anifrolumab | Phase III |
| Iberdomide | Phase II |
CLE, cutaneous lupus erythematosus.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.